Impact of regulatory interventions to restrict the combined use of renin–angiotensin system blockers: A Danish nationwide drug utilisation study

This study aimed to evaluate the impact of the risk minimisation measures issued by the European Medicines Agency in 2014 to restrict the combined use of renin–angiotensin system (RAS) blocking agents in Denmark. Data from the Danish National Prescription Registry covering all medications dispensed...

Descripción completa

Detalles Bibliográficos
Autores principales: Sindahl, Per, Ofori‐Asenso, Richard, Hallgreen, Christine Erikstrup, Kemp, Kaare, Gardarsdottir, Helga, De Bruin, Marie Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293443/
https://www.ncbi.nlm.nih.gov/pubmed/34519065
http://dx.doi.org/10.1111/bcp.15080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293443/
https://www.ncbi.nlm.nih.gov/pubmed/34519065
http://dx.doi.org/10.1111/bcp.15080

Ejemplares similares